Albumin Gen.2, Catalog 05166861190
Published October 21, 2020 · Recall initiated: August 27, 2020
Summary
FDA records medical device Class III recall Z-0104-2021, published October 21, 2020 and initiated August 27, 2020. Recalling firm: Roche Diagnostics Operations, Inc.; Status: Terminated; Reported quantity: 11963; Lot: lots 43031001, 43718901. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Roche has confirmed customer complaints of low quality (QC) recovery and invalid calibrations for the identified products. A discoloration (yellow color) was observed and is the result of cross contamination between the R1 and R3 reagents.
What to do
Voluntary: Firm initiated
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Roche Diagnostics Operations, Inc.
- Distributor
- Domestic distribution nationwide.
- Lot
- lots 43031001, 43718901
- Risk classification
- Class III
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAcobas HCYS, Homocysteine Enzymatic Assay, Material Number REF 06542921190, for use on cobas c 701/702, inNovember 27, 2024
- FDACreatine Kinase (CK) used on cobas c 311/501/502 and COBAS INTEGRA 400 plus-In vitro test for the quantitativeOctober 2, 2024
- FDAAtellica CH Systems Fructosamine (FRUC)-For in vitro diagnostic use in the quantitative measurement ofOctober 21, 2020
- FDAEzycare Face Mask, Disposable Non Medical Face Masks - Product Usage: marketed under face mask umbrella EUA asOctober 21, 2020
- FDAElecsys Anti-HAV IgM assay-for the in vitro qualitative detection of IgM antibodies to hepatitis A virusDecember 18, 2019
- FDAOnline TDM Vancomycin Gen.3 (100 tests) Catalog # 06779336190 Analyzer/Module: cobas c 311 and cobas c 501/502October 16, 2019
Questions about this recall
Was Albumin Gen.2, Catalog 05166861190 recalled?
Yes. FDA published recall Z-0104-2021 on October 21, 2020. Reported hazard: Roche has confirmed customer complaints of low quality (QC) recovery and invalid calibrations for the identified products. A discoloration (yellow color) was observed and is the result of cross contamination between the R1 and R3 reagents.
What should I do if I have this product?
Voluntary: Firm initiated